Transcatheter Arterial Chemoembolization (TACE)

PROCEDURE4 trials

Sponsors

Hospital Authority, Hong Kong, University of Pittsburgh, Fudan University, Shenzhen Hornetcorn Bio-technology Company, LTD

Conditions

Carcinoma, HepatocellularDigestive System NeoplasmsHepatocellular CarcinomaNeoplasms

Phase 2

DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma

Shenzhen Hornetcorn Bio-technology Company, LTDDigestive System Neoplasms, Hepatocellular Carcinoma, Neoplasms

Start: 2015-05-31End: 2018-12-31Target: 60Updated: 2016-05-24

Phase 4

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy

Fudan UniversityHepatocellular Carcinoma

Start: 2010-04-30End: 2012-12-31Target: 80Updated: 2010-04-13

Unknown Phase

A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer

Hospital Authority, Hong KongCarcinoma, Hepatocellular

Start: 2004-03-31End: 2008-12-31Target: 100Updated: 2010-07-07

SBRT + TACE for Primary Hepatocellular Carcinoma

WithdrawnNCT00746655

University of PittsburghHepatocellular Carcinoma

Start: 2009-07-31End: 2015-12-31Updated: 2015-12-24